Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID)

The summary for the Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID)
	CFDA Number:	93.065
	CFDA Description:	Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-EH-11-001
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Mar 17, 2011
	Creation Date:	May 06, 2011
	Original Closing Date for Applications:	May 16, 2011 Letter of Intent Due Date: April 15, 2011 Application Due Date: May 16, 2011
	Current Closing Date for Applications:	May 31, 2011 Letter of Intent Due Date: April 15, 2011 Application Due Date: May 31, 2011
	Archive Date:	Jun 15, 2011
	Expected Number of Awards:	2
	Estimated Total Program Funding:	900,000
	Federal Grant Award Ceiling:	450,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible Applicants Eligible Organizations Eligible applicants are State or Territorial Public Health Newborn Bloodspot Screening Programs. Eligible applicants may apply either as: an individual organization, or as the lead member of a consortium of multiple State Public Health laboratories with an existing Newborn Bloodspot Screening program, or in partnership with an organization from the following list: Public nonprofit organizations; private nonprofit organizations; for profit organizations; small, minority, and women-owned businesses; universities; colleges; research institutions; hospitals; community-based organizations; faith-based organizations; federally recognized or state-recognized American Indian/Alaska Native tribal governments; American Indian/Alaska Native tribally designated organizations; Alaska Native health corporations; urban Indian health organizations; tribal epidemiology centers; state and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau); and political subdivisions of states (in consultation with states). A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.
Grant Description: The purpose of this funding opportunity is to promote research in support of the implementation of first time newborn bloodspot screening programs for SCID and is targeted to programs which were not fully operational before January 2011.Objectives: To expand laboratory capacity for SCID newborn screening in the US by the funding of capital costs for purchases (such as laboratory equipment, reagents, etc) in order to implement SCID testing To increase the pool of laboratory scientists with knowledge and skill in conducting newborn screening for SCID To provide training for the public health community (e.g., laboratory scientists, healthcare providers, NBS program officials, primary care physicians) about NBS tests for SCID and to foster its integration into the standard of care for communities To encourage participation in collaborative ventures to explore data analysis and statistical algorithms that can improve the predictive values of primary SCID NBS tests Note: Awards are intended as seed funding, and applicants must demonstrate a commitment to secure and sustain funds from other sources for routine program operation beyond the project period.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Centers for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700

PGOTIM@cdc.gov [PGOTIM@cdc.gov]
Similar Government Grants: • APHL-CDC PARTNERSHIP FOR QUALITY LABORATORY MEDICINE; • Association of Public Health Laboratories (APHL); • Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Scree...